These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5648218)

  • 21. Potential usefulness of sevelamer hydrochloride to improve cardiac outcome in patients with coronary disease and normal renal function.
    Di Vito C; Bruno A; Emanuele E
    Med Hypotheses; 2007; 68(5):1182-3. PubMed ID: 17137729
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of creatine supplementation in cystic fibrosis: results of a pilot study.
    Braegger CP; Schlattner U; Wallimann T; Utiger A; Frank F; Schaefer B; Heizmann CW; Sennhauser FH
    J Cyst Fibros; 2003 Dec; 2(4):177-82. PubMed ID: 15463870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of 1035 M.D. in the treatment of chronic coronary insufficiency. 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1968 Oct; ():Suppl 6:800-3. PubMed ID: 5748097
    [No Abstract]   [Full Text] [Related]  

  • 24. No effect of creatine on respiratory distress in amyotrophic lateral sclerosis.
    Drory VE; Gross D
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):43-6. PubMed ID: 12061948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of coronary insufficiency. Clinical evaluation of a vasodilator agent and tranquilizer drug combination (Ro 4-6486)].
    Buzzi A
    Med Panam; 1963 Aug; 21(4):97-9. PubMed ID: 5900011
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of aminodarone in the symptomatic treatment of coronary insufficiency in patients (40 cases)].
    Reymond C
    Therapie; 1970; 25(2):323-9. PubMed ID: 5526210
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of heparin on the physical loading tolerance of chronic coronary insufficiency patients].
    Kucheriavyĭ PG; Terno VS; Taktuk EE
    Vrach Delo; 1981 Sep; (9):39-41. PubMed ID: 7303609
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of heart insufficiency with Intensain-Lanicor].
    Lordick H
    Dtsch Med J; 1968 Jun; 19(11):435-9. PubMed ID: 5732166
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of syncoumar on the status of the coagulating and anticoagulating systems of the blood in patients with myocardial infarct and chronic coronary insufficiency].
    Orlova NP
    Ter Arkh; 1966 Apr; 38(4):43-7. PubMed ID: 5984661
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
    Candau LA; Pereira LS; Lavall MA; Carvalho CR
    Arq Bras Cardiol; 1982 Aug; 39(2):135-8. PubMed ID: 6763518
    [No Abstract]   [Full Text] [Related]  

  • 31. [Improved exercise tolerance in patients with coronary insufficiency treated with i.v. aminophylline].
    Horacek T; Bischoff KO; Bucher P; Küter L; Hager W
    Med Welt; 1983 Jun; 34(24):694-5. PubMed ID: 6888236
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oral administration of a polarizing mixture in patients with coronary insufficiency].
    Masior J; Zgórniak M
    Przegl Lek; 1966; 22(5):387-90. PubMed ID: 5911970
    [No Abstract]   [Full Text] [Related]  

  • 33. Treating acute coronary insufficiency with antibiotics.
    Milani KS
    J Fam Pract; 1997 Nov; 45(5):379. PubMed ID: 9374959
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk stratification and treatment benefits in patients with non-ST-elevation acute coronary syndromes.
    White HD; Wong CK
    Eur Heart J; 2002 Feb; 23(3):187-91. PubMed ID: 11792130
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the treatment of chronic cardiac insufficiency with acetyldigitoxin].
    Szakolczai I; Tiszai A
    Wien Med Wochenschr; 1966 Apr; 116(18):400-3. PubMed ID: 5985198
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of prolonged beta-adrenergic blockade on myocardial energy metabolism in coronary occlusion].
    Sysoliatina NA
    Farmakol Toksikol; 1982; 45(4):41-6. PubMed ID: 7128783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thromboelastographic control of blood coagulability during anticoagulant therapy of patients with coronary insufficiency under ambulatory conditions].
    Demin AA; Romashchov VP
    Klin Med (Mosk); 1966 Jan; 44(1):51-4. PubMed ID: 5984426
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience with the use of sodium hydroxybutyrate in patients with acute coronary insufficiency and cardiac rhythm disorders].
    Popov VG; Kharkevich DA; Syrkin AL; Basistov AF; Lazebnik LB; Lazutin VK
    Ter Arkh; 1968 Dec; 40(12):44-7. PubMed ID: 5746542
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nitrosorbide in the treatment of cardiac insufficiency in patients with ischemic heart disease].
    Kupchinskaia EG
    Vrach Delo; 1983 Jan; (1):21-3. PubMed ID: 6868491
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the action of propranolol in chronic coronary insufficiency].
    Cherchi A; Lixi M; Raffo M; Porrazzo G; Bina M; Mazza B
    Boll Soc Ital Cardiol; 1966; 11(4):1498-503. PubMed ID: 5992065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.